SynAct Pharma AB (FRA:8F8)
1.826
+0.020 (1.11%)
At close: Feb 20, 2026
19.66% (1Y)
| Market Cap | 98.49M +55.1% |
| Revenue (ttm) | n/a |
| Net Income | -10.24M |
| EPS | -0.20 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 5.26 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 11 |
| Open | 1.808 |
| Previous Close | 1.806 |
| Day's Range | 1.808 - 1.826 |
| 52-Week Range | 1.220 - 2.320 |
| Beta | n/a |
| RSI | 45.12 |
| Earnings Date | Feb 18, 2026 |